PT  - JOURNAL ARTICLE
AU  - Barr, Peter B.
AU  - Driver, Morgan N.
AU  - Kuo, Sally I-Chun
AU  - Stephenson, Mallory
AU  - Aliev, Fazil
AU  - Karlsson Linnér, Richard
AU  - Marks, Jesse
AU  - Anokhin, Andrey P.
AU  - Bucholz, Kathleen
AU  - Chan, Grace
AU  - Edenberg, Howard J.
AU  - Edwards, Alexis C.
AU  - Francis, Meredith W.
AU  - Hancock, Dana B.
AU  - Harden, K. Paige
AU  - Kamarajan, Chella
AU  - Kaprio, Jaakko
AU  - Kinreich, Sivan
AU  - Kramer, John
AU  - Kuperman, Samuel
AU  - Latvala, Antti
AU  - Meyers, Jacquelyn L.
AU  - Palmer, Abraham A.
AU  - Plawecki, Martin H.
AU  - Porjesz, Bernice
AU  - Rose, Richard J.
AU  - Schuckit, Marc A.
AU  - Salvatore, Jessica E.
AU  - Dick, Danielle M.
TI  - Clinical, Environmental, and Genetic Risk Factors for Substance Use Disorders: Characterizing Combined Effects across Multiple Cohorts
AID  - 10.1101/2022.01.27.22269750
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.27.22269750
4099  - http://medrxiv.org/content/early/2022/08/04/2022.01.27.22269750.short
4100  - http://medrxiv.org/content/early/2022/08/04/2022.01.27.22269750.full
AB  - Substance use disorders (SUDs) incur serious social and personal costs. Risk for SUDs is complex, ranging from social conditions to individual genetic variation. We examined whether models that include a clinical/environmental risk index (CERI) and polygenic scores (PGS) are able to identify individuals at increased risk of SUD in young adulthood across four longitudinal cohorts for a combined sample of N = 15,134. Our analyses included participants of European (NEUR = 12,659) and African (NAFR = 2,475) ancestries. SUD outcomes included: 1) alcohol dependence, 2) nicotine dependence; 3) drug dependence, and 4) any substance dependence. In the models containing the PGS and CERI, the CERI was associated with all three outcomes (ORs = 1.37 – 1.67). PGS for problematic alcohol use, externalizing, and smoking quantity were associated with alcohol dependence, drug dependence, and nicotine dependence, respectively (OR = 1.11 – 1.33). PGS for problematic alcohol use and externalizing were also associated with any substance dependence (ORs = 1.09 – 1.18). The full model explained 6% - 13% of the variance in SUDs. Those in the top 10% of CERI and PGS had relative risk ratios of 3.86 - 8.04 for each SUD relative to the bottom 90%. Overall, the combined measures of clinical, environmental, and genetic risk demonstrated modest ability to distinguish between affected and unaffected individuals in young adulthood. PGS were significant but added little in addition to the clinical/environmental risk index. Results from our analysis demonstrate there is still considerable work to be done before tools such as these are ready for clinical applications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was was supported by the National Institute on Alcohol Abuse and Alcoholism and the National Institute of Drug Abuse of the National Institutes of Health under award numbers R01AA015416, R01DA050721, R01DA042090, and K02AA018755; the Academy of Finland (grants 100499, 205585, 118555, 141054, 265240, 308248, 308698 and 312073); the Scientific and Technological Research Council of Turkey (TÜBİTAK) under award number 114C117 (FA); and the Sigrid Juselius Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Virginia Commonwealth University waived ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in the present study are available upon application and approval by the constituent cohorts. https://osf.io/fg9rj/ https://osf.io/etbw8